Division of Hematology and Medical Oncology, Weill Cornell Medical College, Cornell University, New York, NY 10065, USA.
Cell Rep. 2013 Aug 15;4(3):578-88. doi: 10.1016/j.celrep.2013.06.016. Epub 2013 Aug 1.
The BCL6 transcriptional repressor is required for the development of germinal center (GC) B cells and diffuse large B cell lymphomas (DLBCLs). Although BCL6 can recruit multiple corepressors, its transcriptional repression mechanism of action in normal and malignant B cells is unknown. We find that in B cells, BCL6 mostly functions through two independent mechanisms that are collectively essential to GC formation and DLBCL, both mediated through its N-terminal BTB domain. These are (1) the formation of a unique ternary BCOR-SMRT complex at promoters, with each corepressor binding to symmetrical sites on BCL6 homodimers linked to specific epigenetic chromatin features, and (2) the "toggling" of active enhancers to a poised but not erased conformation through SMRT-dependent H3K27 deacetylation, which is mediated by HDAC3 and opposed by p300 histone acetyltransferase. Dynamic toggling of enhancers provides a basis for B cells to undergo rapid transcriptional and phenotypic changes in response to signaling or environmental cues.
BCL6 转录抑制因子是生发中心 (GC) B 细胞和弥漫性大 B 细胞淋巴瘤 (DLBCL) 发育所必需的。尽管 BCL6 可以募集多个核心抑制剂,但它在正常和恶性 B 细胞中的转录抑制作用机制尚不清楚。我们发现,在 B 细胞中,BCL6 主要通过两种独立的机制发挥作用,这两种机制共同对 GC 的形成和 DLBCL 至关重要,均通过其 N 端 BTB 结构域介导。这些机制是:(1)在启动子处形成独特的 BCOR-SMRT 三元复合物,每个核心抑制剂都与连接到特定表观遗传染色质特征的 BCL6 同源二聚体上的对称位点结合;(2)通过 SMRT 依赖性 H3K27 去乙酰化作用,将活性增强子“切换”到一种静止但未被擦除的构象,该过程由 HDAC3 介导,并被 p300 组蛋白乙酰转移酶所拮抗。增强子的动态切换为 B 细胞提供了基础,使其能够在受到信号或环境线索的刺激时迅速发生转录和表型变化。